# SCOLR Pharma, Inc.: Form D filings

SCOLR Pharma, Inc., a pharmaceuticals company in Bellevue, WA, filed 4 Form D notices with the SEC between 2010 and 2012. The latest, on May 18, 2012, reports $308,000 sold of a $1.4 million offering to 7 investors.

Find out what SCOLR Pharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20SCOLR%20Pharma%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=SCOLR%20Pharma%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fscolr-pharma-inc-934936)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20SCOLR%20Pharma%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=SCOLR%20Pharma%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fscolr-pharma-inc-934936)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Washington](https://specstream.ai/data/form-d/state/washington): 1,095 rows, by operating companies, filed since November 1, 2024, $54.75, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/washington
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 13400 NE 20TH STREET, SUITE 44, Bellevue, WA, 98005
- Phone: (425) 368-1050
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 934936

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 18, 2012 | New notice | $1,350,000 | $308,000 | $1,042,000 | 7 | May 4, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/934936/000146190212000002/0001461902-12-000002-index.htm) |
| Jun 30, 2011 | Amendment | $1,195,200 | $1,195,200 | $0 | 82 | Jun 16, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/934936/000146190211000002/0001461902-11-000002-index.htm) |
| Jun 23, 2011 | New notice | $1,750,000 | $1,001,200 | $748,800 | 62 | Jun 16, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/934936/000146190211000001/0001461902-11-000001-index.htm) |
| Mar 18, 2010 | New notice | $4,130,000 | $4,130,000 | $0 | 123 | Mar 4, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/934936/000093493610000007/0000934936-10-000007-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| MaryLou W. Arnett | Director |  |
| Michael N. Taglich | Director |  |
| Wayne L Pines | Director |  |
| Herbert L. Lucas | Director |  |
| Jeffrey B. Reich | Director |  |
| Stephen J. Turner | Executive Officer |  |
| Carl J. Johnson | Director |  |

## Other pharmaceuticals companies in Washington that filed recently

- [Aptevo Therapeutics Inc.](https://specstream.ai/data/form-d/company/aptevo-therapeutics-inc-1671584) $3.5 million · Aug 26, 2026

[Every Form D from the week of May 14, 2012](https://specstream.ai/data/form-d/week/2012-05-14) · [All recent filings in Washington](https://specstream.ai/data/form-d/state/washington) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what SCOLR Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).